Background {#Sec1}
==========

Approximately 234 million major surgical procedures are undertaken worldwide every year \[[@CR1]\]. Among these, approximately 7 million patients develop major complications resulting in one million deaths during surgery or in-hospital stay, contributing to an estimated mortality rate after anesthesia of 34 per million \[[@CR1], [@CR2]\]. According to the 'Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications' (LAS VEGAS) trial, postoperative pulmonary complications (PPC) occur in a significant proportion of surgical patients \[[@CR3]\]. However, since thoracic surgery requires a differentiated ventilatory approach, those patients were excluded from the primary analysis of the LAS VEGAS study. In thoracic surgery, conventional methods to prevent and treat hypoxemia during one lung ventilation (OLV) can be harmful to the lung tissue: high fraction of inspired oxygen (FIO2) and low (or no) positive end--expiratory pressure (PEEP) both can promote atelectasis, whereas high tidal volume (VT) can cause baro- and volutrauma \[[@CR4]\]. The type of thoracic surgery (open or endoscopic) as well as the intraoperative mechanical ventilation settings may also influence PPCs.

Intraoperative mechanical ventilation with low V~T~, low driving pressure, and low to moderate PEEP improved postoperative lung function and even outcome in patients undergoing open abdominal surgery \[[@CR5], [@CR6]\]. When low V~T~ was used in abdominal surgery, high PEEP combined with recruitment maneuvers, as compared to low PEEP without recruitment maneuvers, did not add to the protection against PPCs \[[@CR7]\].

The present study aimed to characterize the current mechanical ventilation practice during general anesthesia for thoracic surgery, describe the incidence of PPCs, and investigate possible associations between type of surgery (open vs. endoscopic), type of ventilation (OLV or two lung ventilation) and risk for PPCs (low risk vs high) with the incidence of PPCs. We hypothesized that intraoperative mechanical ventilation, as recommended in the literature, namely with low V~T~, low driving pressure, and low to moderate PEEP \[[@CR8]\], is not commonly used during thoracic surgery, and that the incidence of PPCs is higher in this surgical population than in non-thoracic surgery.

Methods {#Sec2}
=======

Study design and sites {#Sec3}
----------------------

The present work is a post hoc analysis of the 'Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications' (LAS VEGAS trial) \[[@CR3]\]. The LAS VEGAS trial protocol was first approved by the institutional review board of the Academic Medical Center, Amsterdam, The Netherlands (W12_190\#12.17.0227) and registered at clinicaltrials.gov (NCT01601223). The protocol of this trial was published elsewhere \[[@CR9]\].

Study population and data collection {#Sec4}
------------------------------------

Consecutive adult patients receiving invasive ventilation during general anesthesia for elective or non--elective surgery were eligible for participation in the study, which ran for seven predefined days in each country, selected by the national coordinator, in the period between January 14th and March 4th, 2013. Patients were excluded from participation if they were aged \< 18 years, or scheduled for pregnancy related surgery, surgical procedures outside the operating room, or procedures involving cardio-pulmonary bypass.

The patient database of the LAS VEGAS trial was searched for eligible patients who received either open thoracic surgery, thoracoscopic or thoracoscopy assisted surgery (both summarized as endoscopic surgery), with or without OLV. These data have not been considered in previous analyses.

Reasonable parameters of baseline characteristics, intraoperative data and preoperative risk factors for PPCs were identified from previous studies \[[@CR10]--[@CR13]\]. During the intraoperative period, data describing ventilation settings and vital parameters, as well as episodes of hypoxia (SpO~2~ \< 92%), use of recruitment maneuvers, airway pressure reduction, presence of expiratory flow limitation, hypotension (mean arterial pressure \< 60 mmHg), use of vasoactive drugs, and new arrhythmias, was collected. Postoperative residual curarisation with neuromuscular blocking agents (NMBAs), defined as train--of--four stimulation (TOF) ratio \<  0.9, was documented.

The definition of protective mechanical ventilation is still under debate. For this analysis it was based on recent recommendations \[[@CR8], [@CR14]--[@CR16]\]. Patients were considered to be have been protectively ventilated "as recommended" if PEEP ≥5 cmH~2~O and V~T~ ≤ 8 ml/kg PBW during TLV \[[@CR8], [@CR14], [@CR17]\], and PEEP ≥5 cmH~2~O and V~T~ ≤ 5 ml/kg PBW during OLV \[[@CR18]--[@CR20]\].

The occurrence of PPCs is presented as a collapsed composite of PPCs in the first five postoperative days. The following PPCs were scored daily from the day of surgery until hospital discharge or postoperative day 5: 1) need for supplementary oxygen (due to PaO~2~ \< 60 mmHg or SpO~2~ \< 90% in room air, excluding oxygen supplementation given as standard care or as continuation of preoperative therapy), 2) respiratory failure (PaO~2~ \< 60 mmHg or SpO~2~ \< 90% despite oxygen therapy, or need for non-invasive mechanical ventilation), 3) unplanned new or prolonged invasive *or* non--invasive mechanical ventilation, 4) acute respiratory distress syndrome, 5) pneumonia. Severe PPCs were defined as the occurrence of one or more of the complications 2--5. Patient data were anonymized before entry onto a password secured, web--based electronic case record form (OpenClinica, Boston, MA, USA).

Statistical analysis {#Sec5}
--------------------

Patients were stratified into groups based on: 1) use or not of OLV (OLV vs. only TLV); 2) use or not of an endoscopic approach (endoscopic vs. open); and 3) risk for PPC according to ARISCAT (low risk \[ARISCAT \< 26\] vs. moderate-to-high risk \[ARISCAT ≥26\] Supplemental Table 2, Additional file [1](#MOESM1){ref-type="media"}). The ventilatory data, which were collected hourly, were first averaged for each patient according to the number of observations (median of the value). In a longitudinal analysis, this data is presented for the first, second, third, fourth and last hour of surgery. All data are presented for the whole population and for the subgroups. In-hospital length of stay (LOS) and in-hospital mortality was censored at postoperative day 28. Proportions are compared using χ^2^ or Fisher exact tests and continuous variables are compared using the Mann-Whitney *U* Test, as appropriate.

The distributions of combinations of tidal volume size and PEEP level are presented in scatter plots. Cut-offs of 6 ml/kg PBW for tidal volume, and 5 cmH~2~O for PEEP were chosen to form the matrices. These cut-offs were based on widely accepted values of each variable, or according to normal daily practice. The driving pressure was defined as plateau pressure (Pplat) minus the PEEP level.

Kaplan--Meier estimates of the cumulative probability of development of PPC and hospital discharge were performed. Cox proportional hazard models without adjustment for covariates were used to assess the effect of the subgroups on outcome. The proportionality assumption was tested with scaled Schoenfeld residuals. Adjustments for multiple comparisons were not performed and no assumption for missing data was done. Statistical significance was considered to be at two-sided *p* \<  0.05. All analyses were performed with R version 3.4.1 ([http://www.R-project.org/](http://www.r-project.org/)).

Results {#Sec6}
=======

From 10,520 patients enrolled in the LAS VEGAS study, 302 patients underwent thoracic procedures (Supplemental Figure 1, Additional file [1](#MOESM1){ref-type="media"}). Characteristics of patient and surgery are shown in Table [1](#Tab1){ref-type="table"}. In this sub-population of 302 thoracic surgical patients, 55% (168/302) received OLV, 15.2% (46/302) were operated with an endoscopic approach and 87.4% (264/302) had moderate-to-high risk for PPCs. Table 1Pre-Operative Characteristics of the Patients According to SubgroupsAll Patients\
(***n*** = 302)OLV\
(***n*** = 168)TLV\
(***n*** = 134)***p*** valueEndoscopic\
(***n*** = 46)Open\
(***n*** = 256)***p*** valueLow Risk\
(***n*** = 38)High Risk\
(***n*** = 264)***p*** valueAge, years62.0 (50.0--70.8)62.0 (50.0--70.0)62.0 (47.2--71.0)0.79962.0 (49.8--70.8)62.0 (50.0--70.2)0.83937.0 (28.2--46.0)64.0 (54.8--71.2)\<  0.001Male gender181 (59.9)101 (60.1)80 (59.7)0.94123 (50.0)158 (61.7)0.13517 (44.7)164 (62.1)0.040BMI, kg/m^2^25.6 (22.9--28.9)25.7 (23.3--29.3)25.4 (22.5--28.7)0.39825.1 (21.8--27.5)25.7 (23.0--29.3)0.12923.1 (20.9--26.3)25.8 (23.4--29.2)0.010ASA physical status0.5730.880\<  0.001 140 (13.3)22 (13.1)18 (13.5)5 (11.1)35 (13.7)20 (54.1)20 (7.6) 2109 (36.2)60 (35.7)49 (36.8)18 (40.0)91 (35.5)17 (45.9)92 (34.8) 3141 (46.8)82 (48.8)59 (44.4)20 (44.4)121 (47.3)0 (0.0)141 (53.4) 411 (3.7)4 (2.4)7 (5.3)2 (4.4)9 (3.5)0 (0.0)11 (4.2)ARISCAT score40.0 (27.0--49.5)40.0 (27.0--47.0)39.0 (27.0--50.0)0.75535.0 (27.0--43.0)40.0 (27.0--50.0)0.01824.0 (24.0--24.0)43.0 (27.0--50.0)\< 0.001Functional status Independent270 (89.4)153 (91.1)117 (88.0)0.53643 (93.5)227 (89.0)0.43836 (94.7)234 (89.0) Partially dependent26 (8.6)12 (7.1)14 (10.5)2 (4.3)24 (9.4)2 (5.3)24 (9.1)0.772 Totally dependent5 (1.7)3 (1.8)2 (1.5)1 (2.2)4 (1.6)0 (0.0)5 (1.9)Smoking83 (27.5)43 (25.6)40 (29.9)0.41012 (26.1)71 (27.7)0.8179 (23.7)74 (28.0)0.574Transfusion (\<  24 h)6 (2.0)2 (1.2)4 (3.0)0.4110 (0.0)6 (2.3)0.5950 (0.0)6 (2.3)1.000Respiratory infection (\<  30 d)24 (7.9)17 (10.1)7 (5.2)0.1182 (4.3)22 (8.6)0.5510 (0.0)24 (9.1)0.054Recent MV (\<  30 d)8 (2.6)5 (3.0)3 (2.2)1.0000 (0.0)8 (3.1)0.6120 (0.0)8 (3.0)0.602Co-morbidities COPD54 (17.9)35 (20.8)19 (14.2)0.1336 (13.0)48 (18.8)0.3521 (2.6)53 (20.1)0.005 Apnea5 (1.7)1 (0.6)4 (3.0)0.1741 (2.2)4 (1.6)0.5640 (0.0)5 (1.9)1.000 Liver cirrhosis2 (0.7)2 (1.2)0 (0.0)0.5040 (0.0)2 (0.8)1.0000 (0.0)2 (0.8)1.000 Chronic kidney failure7 (2.3)5 (3.0)2 (2.0)0.4681 (2.2)6 (2.3)1.0000 (0.0)7 (2.7)0.601 Heart failure23 (7.6)9 (5.4)14 (10.4)0.0972 (4.3)21 (8.2)0.5480 (0.0)23 (8.7)0.092 Neuro disease8 (2.6)5 (5.0)3 (2.2)1.0002 (4.3)6 (2.3)0.3502 (5.3)6 (2.3)0.265**Laboratorial tests and vital signs**SpO~2~, %97.0 (95.0--98.0)97.0 (95.0--98.0)97.0 (95.0--98.0)0.34798.0 (95.0--99.0)97.0 (95.0--98.0)0.23298.0 (97.0--99.0)97.0 (95.0--98.0)\< 0.001Hemoglobin, g/dL13.5 (12.4--14.8)13.5 (12.4--14.5)13.4 (12.5--15.0)0.70013.3 (12.9--14.6)13.6 (12.3--14.8)0.77314.3 (13.3--15.2)13.4 (12.3--14.6)0.002WBC, cell/mm^3^7150.0 (6000.0--9000.0)7000.0 (6000.0--9000.0)7565.0 (6000.0--9150.0)0.7558000.0 (6000.0--9912.5)7000.0 (6000.0--9000.0)0.3447000.0 (6000.0--8125.0)7300.0 (6000.0--9000.0)0.506**Surgical characteristics**Procedure^a^ Vascular2 (0.7)0 (0.0)2 (1.5)0.1960 (0.0)2 (0.8)1.0000 (0.0)2 (0.8)1.000 Cardiac12 (4.0)0 (0.0)12 (9.0)\<  0.0011 (2.2)11 (4.3)0.7000 (0.0)12 (4.5)0.374 Lung / Pleural231 (76.5)152 (90.5)79 (59.0)\<  0.00134 (73.9)197 (77.0)0.65427 (71.1)204 (77.3)0.397 Other64 (21.2)21 (12.5)43 (32.1)\<  0.00111 (23.9)53 (20.7)0.62312 (31.6)52 (19.7)0.093Condition Elective283 (93.7)160 (95.2)123 (91.8)0.45441 (91.3)241 (94.1)0.14836 (94.7)247 (93.6) Urgency13 (4.3)5 (3.0)8 (6.0)4 (8.7)9 (3.5)2 (5.3)11 (4.2)0.856 Emergency6 (2.0)3 (1.8)3 (2.2)0 (0.0)6 (2.3)0 (0.0)6 (2.3)Planned duration  ≤ 2 h136 (45.0)73 (43.5)63 (47.0)0.42728 (60.9)108 (42.2)0.06130 (78.9)106 (40.2) 2--3 h95 (31.5)58 (34.5)37 (27.6)11 (23.9)84 (32.8)6 (15.8)89 (33.7)\<  0.001  \> 3 h71 (23.5)37 (22.0)34 (25.4)7 (15.2)64 (25.0)2 (5.3)69 (26.1)Antibiotic prophylaxis266 (88.1)146 (86.9)120 (89.6)0.48038 (82.6)228 (89.1)0.21327 (71.1)239 (90.5)\<  0.001Epidural anesthesia72 (23.8)48 (28.6)24 (17.9)0.3075 (10.9)67 (26.2)0.0244 (10.5)68 (25.8)0.039Type of tube Endotracheal84 (27.8)11 (6.5)73 (54.5)\<  0.00124 (52.2)60 (23.4)0.00115 (39.5)69 (26.1) Bronchus blocker19 (6.3)12 (7.1)7 (5.2)1 (2.2)18 (7.0)2 (5.3)17 (6.4)0.295 SGA6 (2.0)2 (1.2)4 (3.0)0 (0.0)6 (2.3)1 (2.6)5 (1.9) DLT193 (63.9)143 (85.1)50 (37.3)21 (45.7)172 (67.2)20 (52.6)173 (65.5)Duration of surgery, min105.0 (55.0--174.2)104.0 (57.5--164.8)105.0 (55.0--180.0)0.83662.5 (45.0--131.2)110.0 (62.2--180.0)0.00355.0 (41.2--80.0)115.0 (62.2--180.8)\< 0.001Duration of anesthesia, min145.0 (90.0--225.0)147.5 (97.8--225.0)145.0 (90.0--235.0)0.651105.0 (80.0--153.8)152.0 (100.0--236.0)0.00188.0 (64.5--120.0)160.0 (100.0--240.0)\< 0.001Values are presented as median (interquartile range) or number (percentage). *p* values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney *U* Test for continuous variables*ARISCAT: ASA* American Society of Anesthesiology recommended physical status, *BMI* Body mass index*, COPD* Chronic obstructive pulmonary disease, *DLT* Double-lumen tube, *MV* Mechanical ventilation, *OLV* One-lung ventilation*, SGA* Supraglottic airway, *SpO*~*2*~ Pulse oximetry, *TLV* Total lung ventilation, *WBC* White blood count;^a^more than one option allowed

Characteristics of patients undergoing procedures with OLV vs. TLV, and endoscopic vs. open were comparable. Patients with moderate-to-high risk for PPCs were different from those at low risk with respect to age, gender, BMI, ASA status, COPD prevalence and planned duration of surgery (Table [1](#Tab1){ref-type="table"}).

Intra-operative characteristics {#Sec7}
-------------------------------

Patients operated under OLV received more often double-lumen tubes and had more frequently lung or pleural surgery than those operated under TLV (Table [1](#Tab1){ref-type="table"}). Use of epidural anesthesia was less and duration of surgery shorter in endoscopic compared to non-endoscopic surgery (Table [1](#Tab1){ref-type="table"}).

Patients at moderate-to-high risk for PPC received more frequently antibiotic prophylaxis and epidural anesthesia, and had longer duration of surgery as well as anesthesia, compared with patients at low risk (Table [1](#Tab1){ref-type="table"}).

The amounts of crystalloids, colloids, albumin and packed red blood cells was higher in open vs. endoscopic surgery, and in patients at moderate-to-high vs. low risk for PPC (Table [2](#Tab2){ref-type="table"}). Table 2Intra-Operative Characteristics of the Patients According to SubgroupsAll Patients\
(***n*** = 302)OLV\
(***n*** = 168)TLV\
(***n*** = 134)***p*** valueEndoscopic\
(***n*** = 46)Open\
(***n*** = 256)***p*** valueLow Risk\
(***n*** = 38)High Risk\
(***n*** = 264)***p*** value**Ventilation and vital signs**Ventilatory mode Volume controlled209 (70.8)121 (73.3)88 (67.7)0.05528 (65.1)181 (71.8)0.28532 (91.4)177 (68.1) Pressure controlled51 (17.3)28 (17.0)23 (17.7)7 (16.3)44 (17.5)2 (5.7)49 (18.8) Pressure support3 (1.2)3 (1.8)0 (0.0)0 (0.0)3 (1.2)0 (0.0)3 (1.2)0.109 Spontaneous8 (2.7)1 (0.6)7 (5.4)3 (7.0)5 (2.0)0 (0.0)8 (3.1) Other24 (8.1)12 (7.3)12 (9.2)5 (11.6)19 (7.5)1 (2.9)23 (8.8)V~T~, ml472.2 (400.5--525.0)453.5 (398.4--510.0)475.0 (430.6--549.0)0.015468.8 (400.0--544.5)472.2 (405.6--525.0)0.895483.2 (443.1--543.9)468.5 (400.0--525.0)0.102V~T~, ml/kg PBW^a^7.6 (6.3--8.4)7.4 (6.0--8.3)7.6 (6.6--8.5)0.0507.6 (6.2--8.8)7.5 (6.3--8.3)0.2257.6 (7.0--8.3)7.5 (6.2--8.4)0.587Peak pressure, cmH~2~O^a^20.0 (17.5--24.0)21.0 (18.0--25.0)19.0 (16.0--23.0)0.00120.0 (16.2--23.0)20.0 (18.0--24.0)0.18718.5 (15.6--22.0)20.0 (18.0--24.1)0.068Plato pressure, cmH~2~O^a^17.8 (15.0--21.0)18.2 (16.0--21.4)16.5 (13.1--20.0)0.00416.0 (12.5--20.2)18.0 (15.0--21.0)0.11815.8 (13.0--18.9)18.0 (15.5--21.0)0.010PEEP, cmH~2~O^a^4.0 (1.5--5.0)4.5 (2.4--5.0)3.0 (1.5--5.0)0.0063.0 (1.5--5.0)4.0 (2.0--5.0)0.1762.0 (0.0--5.0)4.0 (2.0--5.0)0.008Driving pressure, cmH~2~O^a^14.0 (11.0--17.0)14.5 (12.0--17.5)13.0 (10.5--16.0)0.01613.0 (10.8--16.0)14.0 (11.5--17.0)0.38914.0 (10.5--16.0)14.0 (11.5--17.0)0.216Respiratory rate, bpm12.0 (12.0--14.0)12.0 (12.0--15.0)12.0 (12.0--14.0)0.12812.0 (11.1--14.4)12.0 (12.0--14.0)0.71512.0 (12.0--13.5)12.0 (12.0--14.5)0.644FiO~2~, %65.0 (50.0--80.0)65.8 (50.0--85.0)63.5 (50.0--80.0)0.29470.0 (58.5--83.6)64.5 (50.0--80.0)0.15168.2 (50.0--75.0)65.0 (50.0--84.0)0.543SpO~2~, %99.0 (97.5--100.0)98.5 (97.0--100.0)99.0 (98.0--100.0)0.03999.0 (98.0--99.9)99.0 (97.5--100.0)0.72499.0 (98.0--100.0)99.0 (97.5--100.0)0.352MAP, mmHg78.0 (71.0--86.6)78.0 (71.0--86.0)78.0 (71.0--88.0)0.94080.8 (74.0--95.0)77.5 (70.0--85.0)0.00977.5 (71.5--91.6)78.0 (71.0--86.0)0.474Heart rate, bpm73.5 (64.5--82.0)73.5 (64.5--82.5)73.5 (65.0--81.1)0.89373.2 (65.2--79.0)74.0 (64.5--82.0)0.66375.0 (70.0--81.5)73.5 (63.6--82.0)0.223RM105 (34.8)71 (42.3)34 (25.4)0.00213 (28.3)92 (35.9)0.3147 (18.4)98 (37.1)0.023 In the last hour68 (22.5)52 (31.0)16 (11.9)\<  0.0016 (13.0)62 (24.2)0.0942 (5.3)66 (25.0)0.006Number of RM0.0 (0.0--1.0)0.0 (0.0--1.0)0.0 (0.0--0.8)0.0030.0 (0.0--1.0)0.0 (0.0--1.0)0.3970.0 (0.0--0.0)0.0 (0.0--1.0)0.020Protective ventilation41 (14.8)13 (8.3)28 (23.5)\<  0.00110 (24.4)31 (13.2)0.0914 (11.4)37 (15.4)0.798**Anesthesia characteristics**Type of anesthesia TIVA56 (18.5)25 (14.9)31 (23.1)0.01210 (21.7)46 (18.0)0.2876 (15.8)50 (18.9) Volatile188 (62.3)117 (69.6)71 (53.0)31 (67.4)157 (61.3)22 (57.9)166 (62.9)0.483 Mixed58 (19.2)26 (15.5)32 (23.9)5 (10.9)53 (20.7)10 (26.3)48 (18.2)Opioids Short acting66 (21.9)39 (23.2)27 (20.3)0.15114 (30.4)52 (20.4)0.30611 (28.9)55 (20.9) Long acting202 (66.9)106 (63.1)96 (72.2)28 (60.9)174 (68.2)24 (63.2)178 (67.7)0.475 Both33 (10.9)23 (13.7)10 (7.5)4 (8.7)29 (11.4)3 (7.9)30 (11.4)Total Fluids Crystalloids, ml1000.0 (875.0--2000.0)1000.0 (1000.0--1750.0)1000.0 (800.0--2000.0)0.949900.0 (500.0--1100.0)1130.0 (1000.0--2000.0)\< 0.0011000.0 (670.0--1000.0)1100.0 (1000.0--2000.0)\< 0.001 Colloids, ml500.0 (67.5--700.0)500.0 (0.0--500.0)500.0 (500.0--1000.0)0.0760.0 (0.0--500.0)500.0 (450.0--850.0)0.0270.0 (0.0--500.0)500.0 (500.0--1000.0)0.007 Albumin, ml0.0 (0.0--0.0)0.0 (0.0--0.0)0.0 (0.0--12.2)0.7550.0 (0.0--0.0)0.0 (0.0--0.0)0.2120.0 (0.0--0.0)0.0 (0.0--0.0)0.134 PRBC, units0.0 (0.0--2.0)0.0 (0.0--1.0)1.0 (0.0--2.0)0.1620.0 (0.0--0.0)0.0 (0.0--2.0)0.0450.0 (0.0--0.0)0.0 (0.0--2.0)0.017Reversal of NMBA115 (38.1)72 (43.1)43 (32.1)0.05016 (34.8)99 (38.8)0.60314 (36.8)101 (38.4)0.853Values are presented as median (interquartile range) or number (percentage). *p* values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney *U* Test for continuous variables *bpm* beats per minute, *etCO*~*2*~ End-tidal carbon dioxide, *FiO*~*2*~ Inspired fraction of oxygen, *MAP* Mean arterial pressure, *mpm* Movements per minute, *NMBA* Neuromuscular blocking agents, *OLV* One lung ventilation, *PBW* Predicted body weight, *PEEP* Positive end-expiratory pressure, *PRBC* Packed red blood cells, *RM* Recruitment maneuver, *SpO*~*2*~ Pulse oximetry, *TIVA* Total intravenous anesthesia, *TLV* Total lung ventilation, *V*~*T*~ Tidal volume^a^data presented as the median used through surgery

Mechanical ventilation {#Sec8}
----------------------

Patients were ventilated with V~T~ of 7.4 ± 1.6 ml/kg PBW, PEEP of 3.5 ± 2.4 cmH~2~O, and driving pressure of 14.4 ± 4.6 cmH~2~O (Table [2](#Tab2){ref-type="table"}). Compared to patients operated solely under TLV, patients receiving OLV had lower V~T~, higher peak, plateau and driving pressures, as well as PEEP and respiratory rate, and received higher number of recruitment maneuvers (Table [2](#Tab2){ref-type="table"}). Protective ventilation was used in 14.8% (41/302) of all patients, mainly during TLV. The ventilatory management of patients undergoing endoscopic and non-endoscopic procedures did not differ significantly. Patients at moderate-to-high risk for PPC had higher levels of PEEP, and received more recruitment maneuvers than patients at low risk (Table [2](#Tab2){ref-type="table"}).

Values of ventilator settings along time are shown in Supplemental Figures 2 through 4 (Additional file [1](#MOESM1){ref-type="media"}). Patients operated under OLV had higher FiO~2~ compared with patients operated under TLV (Supplemental Figure 2, Additional file [1](#MOESM1){ref-type="media"}). The combinations of V~T~ and PEEP according to subgroups are shown in Supplemental Figures 5 through 7 (Additional file [1](#MOESM1){ref-type="media"}).

Primary outcome {#Sec9}
---------------

The overall incidence of PPCs in this population was 45.7% (138/302), and did not differ significantly between OLV vs. TLV (82/168 vs. 56/134, 48.8% vs. 41.8%, *p* = 0.223, total number and percentage respectively), and endoscopic vs. open procedures (16/46 vs. 122/256, 34.8% vs. 47.7%, *p* = 0.106, total number and percentage respectively, Table [3](#Tab3){ref-type="table"}, Fig. [1](#Fig1){ref-type="fig"}). Patients at moderate-to-high risk showed an increased incidence of PPC compared to patients at lower risk (48.1% vs. 28.9%; hazard ratio, 1.95; 95% CI 1.05--3.61; *p* = 0.033), mainly due to unplanned need for supplemental oxygen (Table [3](#Tab3){ref-type="table"}, Fig. [1](#Fig1){ref-type="fig"}). Table 3Clinical Outcomes of the Patients According to SubgroupsAll Patients\
(***n*** = 302)OLV\
(***n*** = 168)TLV\
(***n*** = 134)***p*** valueEndoscopic\
(***n*** = 46)Open\
(***n*** = 256)***p*** valueLow Risk\
(***n*** = 38)High Risk\
(***n*** = 264)***p*** value**Primary outcome**PPC138 (45.7)82 (48.8)56 (41.8)0.22316 (34.8)122 (47.7)0.10611 (28.9)127 (48.1)0.026 Need of oxygen109 (36.1)65 (38.9)44 (32.8)0.27412 (26.1)97 (38.0)0.1208 (21.1)101 (38.4)0.037 Respiratory failure26 (8.6)15 (8.9)11 (8.2)0.8241 (2.2)25 (9.8)0.1482 (5.3)24 (9.1)0.755 Invasive MV26 (8.6)14 (8.3)12 (9.0)0.8483 (6.5)23 (9.0)0.7781 (2.6)25 (9.5)0.222 NIV15 (5.0)10 (6.0)5 (3.7)0.3772 (4.3)13 (5.1)1.0001 (2.6)14 (5.3)0.702 ARDS4 (1.3)4 (2.4)0 (0.0)0.1320 (0.0)4 (1.6)1.0000 (0.0)4 (1.5)1.000 Pneumonia8 (2.6)6 (3.6)2 (1.5)0.3072 (4.3)6 (2.3)0.3501 (2.6)7 (2.7)1.000**Secondary outcomes**Severe PPC^a^53 (17.5)30 (17.9)23 (17.2)0.8757 (15.2)46 (18.0)0.6514 (10.5)49 (18.6)0.223Intra-OP complications Desaturation61 (20.2)38 (22.6)23 (17.2)0.2407 (15.2)54 (21.1)0.3605 (13.2)56 (21.2)0.247 Unplanned RM48 (15.9)31 (18.5)17 (12.7)0.1737 (15.2)41 (16.0)0.8913 (7.9)45 (17.0)0.149 Pressure reduction36 (11.9)27 (16.1)9 (6.7)0.0125 (10.9)31 (12.1)0.8112 (5.3)34 (12.9)0.281 Flow limitation3 (1.0)2 (1.2)1 (0.8)1.0000 (0.0)3 (1.2)1.0000 (0.0)3 (1.1)1.000 Hypotension102 (33.8)60 (35.7)42 (31.3)0.4248 (17.4)94 (36.7)0.0103 (7.9)99 (37.5)\<  0.001 Vasopressors113 (37.4)65 (38.7)48 (35.8)0.60813 (28.3)100 (39.1)0.1633 (7.9)110 (41.7)\<  0.001 New arrhythmias6 (2.0)3 (1.8)3 (2.2)1.0000 (0.0)6 (2.3)0.5950 (0.0)6 (2.3)1.000ICU admission^b^6 (2.0)2 (1.2)4 (3.0)0.4110 (0.0)6 (2.3)0.5950 (0.0)6 (2.3)1.000Hospital LOS, days6.0 (3.0--10.0)6.0 (4.0--11.0)5.0 (3.0--9.0)0.010^**c**^3.0 (1.0--7.5)6.0 (4.0--10.0)\< 0.001^**c**^4.0 (1.0--6.0)6.0 (4.0--10.0)\< 0.001^**c**^Hospital mortality1 (0.3)1 (0.6)0 (0.0)1.0000 (0.0)1 (0.4)1.0000 (0.0)1 (0.4)1.000Values are presented as median (interquartile range) or number (percentage). *p* values from a Proportions χ2 or Fisher exact tests for proportions and Mann-Whitney *U* Test for continuous variables *ARDS* Acute respiratory distress syndrome, *ICU* Intensive care unit, *Intra-OP* Intraoperative, *LOS* Length of stay, *MV* Mechanical ventilation, *NIV* Non-invasive ventilation, *OLV* One lung ventilation, *PPC* Postoperative pulmonary complication, *RM* Recruitment maneuvers, *TLV* Total lung ventilation^a^excluding need of oxygen^b^unplanned admission^c^*p* value from the Cox proportional hazard modelFig. 1Probability of PPC according to the subgroups assessed. *PPC: postoperative pulmonary complications; OLV: one-lung ventilation; TLV: two-lung ventilation*Non-adjusted hazard ratios.

Secondary outcomes {#Sec10}
------------------

The incidence of severe PPCs, unplanned ICU admission and hospital mortality did not differ among groups (Table [3](#Tab3){ref-type="table"}). The incidence of hypotension was decreased in endoscopic compared to open procedures, and in patients at lower compared to moderate-to-high risk of PPCs (Table [3](#Tab3){ref-type="table"}).

The LOS was increased in patients who developed PPCs (Supplemental Figure 8, Additional file [1](#MOESM1){ref-type="media"}), and shorter in patients operated under OLV vs. TLV, endoscopic vs. open, and those with low vs. moderate-to-high risk for PPC (Table [3](#Tab3){ref-type="table"}, Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Probability of hospital discharge according to the subgroups assessed. *OLV: one-lung ventilation; TLV: two-lung ventilation*. Non-adjusted hazard ratios

Discussion {#Sec11}
==========

In this population of patients undergoing thoracic surgery: 1) mechanical ventilation differed from those recommended for lung protection in 85.2% of all patients; 2) patients under OLV received lower V~T~, higher peak, plateau and driving pressures, higher PEEP levels and respiratory rate, and received more recruitment maneuvers compared with TLV; 3) the overall incidence of PPCs was as high as 45.7%; 4) PPCs were more common among patients with higher ARISCAT score or co-morbidities, but not increased following open vs. endoscopic procedures, or OLV vs. TLV; 6) PPCs were associated with increased LOS.

To our knowledge, this is the first prospective observational investigation addressing the practice of mechanical ventilation and incidence of PPCs in thoracic anesthesia. The main strengths of our study are that data was stored, analyzed and reported according to international standards \[[@CR21]\].

High V~T~ strategies, usually accompanied by low or zero PEEP, have been used to prevent intraoperative atelectasis \[[@CR22], [@CR23]\]. However, this may cause overdistension (volutrauma), and repetitive collapse-reopening of lung units (atelectrauma), which can injure the lungs and lead to PPCs \[[@CR24]\]. A protective ventilation approach consisting mainly of low V~T~ reduces the incidence of PPCs \[[@CR7], [@CR25]\]. This seems to apply also to thoracic anesthesia but this claim is not undisputed \[[@CR26]--[@CR28]\]. The present study shows that protective mechanical ventilation, as recommended, was used in less than 15% of patients undergoing thoracic surgery. Different possible reasons might explain this finding: 1) the concept of protective ventilation during surgery is still not widespread among anesthesiologists; 2) the role of single components of mechanical ventilation in lung protection, especially of PEEP, is still poorly defined, leading anesthesiologists to set values according to their own preferences; 3) sound evidence from large RCTs demonstrating the benefit of protective mechanical ventilation in thoracic surgical patients is still missing; 4) thoracic surgical procedures usually last less than 1 hour, which might be deemed as too short to benefit from protective mechanical ventilation; 5) mechanical ventilation settings guided by driving pressure may result in V~T~ and PEEP outside the range that has been recommended for protective mechanical ventilation.

The incidence of PPCs after surgery is influenced by patient-related factors, and type of surgery. In a mixed surgical population without surgery involving cardiopulmonary bypass, 10.4% of patients developed PPCs within the first postoperative 5 days; values ranged from 6.7% in plastic/cutaneous procedures to 38.2% in transplant surgery \[[@CR3]\]. In open abdominal surgery, PPCs were reported in 10.5 to 39.0% of patients, despite the use of a protective ventilation strategy \[[@CR3], [@CR7], [@CR25]\]. In average, 10.7% of patients at increased risk, for example obese patients, developed PPCs \[[@CR29]\]. In patients undergoing thoracic surgery, an incidence of PPCs between 10.7 and 50% has been reported \[[@CR26], [@CR30]--[@CR32]\]. This relatively wide range is possibly explained by differences in definition of pulmonary complications among trials. The rate of severe PPCs was 17.5% in our thoracic surgery population, which is comparable to the rate of 18.1% reported by Blank and colleagues \[[@CR26]\].

The observation that patients who developed PPCs had more comorbidities and longer LOS is in line with previous studies addressing intraoperative TLV \[[@CR3], [@CR33]\]. The difference in LOS in the subgroups is likely explained by the type of procedure per se, where open approaches require a prolonged treatment due to more complex procedures, independent from the type of mechanical ventilation.

Although the incidence of PPCs was relatively high, neither open thoracic surgery procedures, nor OLV itself were associated with them, especially when taking the infrequent use of protective mechanical ventilation in this population into account. The precise role of PEEP for protective intraoperative mechanical ventilation has been challenged in recent trials \[[@CR7], [@CR34]\]. In fact, it has been suggested that a strategy aimed at permissive atelectasis might be as protective as a strategy to open lungs during surgery \[[@CR14], [@CR35]\]. Our finding that higher V~T~ was not associated with PPCs is intriguingly, but in agreement with data from an observational study reporting that the use of V~T~ as high as 8 mL/kg as even associated with better pulmonary outcome \[[@CR26]\]. Together, these findings suggest that protective OLV settings are more complex than previously thought. Cutoff values, although valuable, must not only consider the interaction among variables, but also a possible role of airway pressures.

Limitations {#Sec12}
-----------

This study has several limitations. First, a one-week inclusion period was relatively short in order to include a high number of patients per center. However, this fact was counterbalanced by the multicenter design. Second, a short inclusion period might have resulted in selection bias, since fluctuation of the severity of cases cannot be ruled out. Nevertheless, the benefits of avoiding changes in therapy during the observation period as a potential confounder should not be underestimated. Third, the definition of protective mechanical ventilation was based on recommendations that are still under debate. Fourth, most study sites included less than 10 patients. This number, however, does not imply lack of experience with the procedure, since thoracic anesthesia per se already requires a substantial degree of expertise. Fifth, the duration of OLV was not investigated and, therefore, the exact contribution of OLV to PPCs cannot be separated from the period under TLV in this sub-population. Sixth, the design of this study precludes the possibility of determining cause-effect relationships, and results must be seen from a hypothesis-generating perspective. Seventh, the fact that data was collected prospectively might have interfered with clinical practice itself, and biased towards the use of protective ventilation. Still, non-protective ventilation was used in a vast majority of patients. Eighth, the total number of patients enrolled allowed analyses of three subgroups only. Potential confounders could be the type of anesthesia (total intravenous anesthesia vs. volatile anesthetics), the type of postoperative analgesia (epidural anesthesia vs. opioids) or the ASA status, which should be subject of future trials.

Conclusions {#Sec13}
===========

The present study provides relevant insight into the practice of mechanical ventilation during thoracic surgery. The data might prove useful for the development of scores for risk prediction in this particular population, allocation of human and financial resources, including need for postoperative monitoring in dedicated units, and also estimation of sample size in interventional trials \[[@CR18]\]. Mechanical ventilation practice did not follow current recommendations for lung protection in the vast majority of patients undergoing thoracic surgery. Although PPCs were common in this population, and associated with increased LOS, their incidence was not higher following open vs. endoscopic or OLV vs. TLV, and not associated with mechanical ventilation settings. It must be emphasized that the lack of association between mechanical ventilation settings and PPCs does not support use of non-protective V~T~ and PEEP in this population.
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ARISCAT Score

:   Assess Respiratory Risk in Surgical Patients in Catalonia Score

ESA

:   European Society of Anaesthesiology

F~I~O~2~

:   Fraction of inspired oxygen

LAS VEGAS

:   Local assessment of ventilatory management during general anesthesia for surgery and effects on postoperative pulmonary complications

LOS

:   Length of stay

NMBAs

:   Neuromuscular blocking agents

OLV

:   Open lung ventilation

PBW

:   Predicted body weight

PEEP

:   Positive end-expiratory pressure

Pplat

:   Plateau pressure

PPCs

:   Postoperative pulmonary complications

PROVEnet

:   Protective Ventilation Network

TLV

:   Total lung ventilation

TOF

:   Train--of--four stimulation

SpO~2~

:   Peripheral oxygen saturation

STROBE

:   Strengthening the reporting of observational studies in epidemiology

V~T~

:   Tidal volume
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